Emergent Biosolutions Inc

NYSE:EBS  
46.95
+0.43 (+0.92%)
Other Pre-Announcement

Emergent Biosolutions Sees Total Revenues For 2021 To Be In Range Of $1,770 Mln -$1,790 Mln

Published: 01/09/2022 19:10 GMT
Emergent Biosolutions Inc (EBS) - Emergent Biosolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results.
Emergent Biosolutions Inc - Expects a Re-baseline of Operations With Stable Revenue Contributions From Core Products and Services Business in 2022.
Emergent - Expects FY Total Revenues of $1.45 Billion at Midpoint and Adjusted EBITDA Margin of 21.5% at Midpoint.
Emergent Biosolutions Inc - Sees 2022 Total Revenues of $1.45 Billion at Midpoint and Adjusted EBITDA Margin of 21.5% at Midpoint.
Emergent Biosolutions Inc - Total Revenues for 2021 Are Expected to Be in Range of $1,770 Million to $1,790 Million.